Dr. Michele Doughty Voeltz, MD

Dr. Voeltz practices at Northside Hospital Gwinnett in Lawrenceville, Georgia, part of Northside Hospital.

Dr. Voeltz's NPI, 1801910393, was assigned on March 19, 2007. Dr. Voeltz graduated from University of Michigan Medical School in 2000. Dr. Voeltz holds Georgia license 51582.

Dr. Voeltz's primary practice is Northside Hospital Gwinnett, at 1000 Medical Center Boulevard, Lawrenceville, GA 30045 in Gwinnett County. The practice phone is (678) 312-4310.

Dr. Voeltz's primary practice is Northside Hospital Gwinnett in Lawrenceville, Georgia, part of Northside Hospital. Dr. Voeltz is also affiliated with Northside Hospital Atlanta. The medical group on file is Northside Hospital Cardiovascular Institute. Dmand AI also links Dr. Voeltz to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Voeltz practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Voeltz's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Voeltz is licensed in Georgia.

CMS data shows 729 Medicare services from Dr. Voeltz across 18 procedure codes in 2024, for 373 Medicare patients. Medicare paid $29,742 for them.

CMS counts 373 Medicare patients who saw Dr. Voeltz in 2024. The largest group is 65 to 74, with 139 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Voeltz's median patient age at 63, with 60% women.

In 2024, Dr. Voeltz wrote 1,342 Medicare Part D claims for 175 patients. 88% of them were for generic drugs. CMS names the drug for 1,122 of them, across 23 drugs with 11 or more claims each, at $127,479 in total drug cost. In 2023, CMS named 910 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Voeltz for performance year 2024, reported as part of a group. Dr. Voeltz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 18 procedures of coronary angioplasty and stenting by Dr. Voeltz, more than 46% of the clinicians it reports for that procedure.

Dmand AI links 19 papers to Dr. Voeltz, published from 2010 to 2024. 2021 was the busiest year, with 2. The most frequent topics are Coronary Artery Bypass, Adenosine Monophosphate and Platelet Aggregation Inhibitors. Dr. Voeltz has published most often in Obstet Gynecol. Dr. Voeltz's most frequent co-authors are Mir Babar Basir, DO, Brittany S. Fuller, MD and Steven V. Manoukian, MD.

Dmand AI links Dr. Voeltz to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Inferior Wall Myocardial Infarction and Anterior Wall Myocardial Infarction.

CMS Open Payments shows 188 general payments to Dr. Voeltz from 43 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 55% of the total. Abiomed paid the most, $16,301.

Dr. Voeltz graduated from University of Michigan Medical School in 2000.